724 related articles for article (PubMed ID: 26444028)
1. Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis.
Yan Y; Ma L; Zhou X; Ponnusamy M; Tang J; Zhuang MA; Tolbert E; Bayliss G; Bai J; Zhuang S
Kidney Int; 2016 Jan; 89(1):68-81. PubMed ID: 26444028
[TBL] [Abstract][Full Text] [Related]
2. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.
Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S
PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059
[TBL] [Abstract][Full Text] [Related]
3. Protein arginine methyltransferase 1 mediates renal fibroblast activation and fibrogenesis through activation of Smad3 signaling.
Zhu Y; Yu C; Zhuang S
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F375-F387. PubMed ID: 31813251
[TBL] [Abstract][Full Text] [Related]
4. Cyclic stretch-induced TGF-β1 and fibronectin expression is mediated by β1-integrin through c-Src- and STAT3-dependent pathways in renal epithelial cells.
Hamzeh MT; Sridhara R; Alexander LD
Am J Physiol Renal Physiol; 2015 Mar; 308(5):F425-36. PubMed ID: 25477471
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction.
Yang J; Dai C; Liu Y
Am J Pathol; 2003 Aug; 163(2):621-32. PubMed ID: 12875981
[TBL] [Abstract][Full Text] [Related]
6. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy.
Pang M; Ma L; Gong R; Tolbert E; Mao H; Ponnusamy M; Chin YE; Yan H; Dworkin LD; Zhuang S
Kidney Int; 2010 Aug; 78(3):257-68. PubMed ID: 20520592
[TBL] [Abstract][Full Text] [Related]
7. JAK3/STAT6 Stimulates Bone Marrow-Derived Fibroblast Activation in Renal Fibrosis.
Yan J; Zhang Z; Yang J; Mitch WE; Wang Y
J Am Soc Nephrol; 2015 Dec; 26(12):3060-71. PubMed ID: 26032813
[TBL] [Abstract][Full Text] [Related]
8. Apamin inhibits renal fibrosis via suppressing TGF-β1 and STAT3 signaling in vivo and in vitro.
Gwon MG; An HJ; Gu H; Kim YA; Han SM; Park KK
J Mol Med (Berl); 2021 Sep; 99(9):1265-1277. PubMed ID: 34031696
[TBL] [Abstract][Full Text] [Related]
9. The proto-oncogene tyrosine protein kinase Src is essential for macrophage-myofibroblast transition during renal scarring.
Tang PM; Zhou S; Li CJ; Liao J; Xiao J; Wang QM; Lian GY; Li J; Huang XR; To KF; Ng CF; Chong CC; Ma RC; Lee TL; Lan HY
Kidney Int; 2018 Jan; 93(1):173-187. PubMed ID: 29042082
[TBL] [Abstract][Full Text] [Related]
10. WISP3 prevents fibroblast-myofibroblast transdifferentiation in NRK-49F cells.
Yi Y; Ma J; Jianrao L; Wang H; Zhao Y
Biomed Pharmacother; 2018 Mar; 99():306-312. PubMed ID: 29353205
[TBL] [Abstract][Full Text] [Related]
11. Heat Shock Protein 72 Antagonizes STAT3 Signaling to Inhibit Fibroblast Accumulation in Renal Fibrogenesis.
Zhou Y; Cao S; Li H; Peng X; Wang Y; Fan J; Wang Y; Zhuang S; Yu X; Mao H
Am J Pathol; 2016 Apr; 186(4):816-28. PubMed ID: 26851345
[TBL] [Abstract][Full Text] [Related]
12. Fyn deficiency attenuates renal fibrosis by inhibition of phospho-STAT3.
Seo HY; Jeon JH; Jung YA; Jung GS; Lee EJ; Choi YK; Park KG; Choe MS; Jang BK; Kim MK; Lee IK
Kidney Int; 2016 Dec; 90(6):1285-1297. PubMed ID: 27616741
[TBL] [Abstract][Full Text] [Related]
13. Rictor/mTORC2 signaling mediates TGFβ1-induced fibroblast activation and kidney fibrosis.
Li J; Ren J; Liu X; Jiang L; He W; Yuan W; Yang J; Dai C
Kidney Int; 2015 Sep; 88(3):515-27. PubMed ID: 25970154
[TBL] [Abstract][Full Text] [Related]
14. The selective A3AR antagonist LJ-1888 ameliorates UUO-induced tubulointerstitial fibrosis.
Lee J; Hwang I; Lee JH; Lee HW; Jeong LS; Ha H
Am J Pathol; 2013 Nov; 183(5):1488-1497. PubMed ID: 24001475
[TBL] [Abstract][Full Text] [Related]
15. Cell-specific delivery of a transforming growth factor-beta type I receptor kinase inhibitor to proximal tubular cells for the treatment of renal fibrosis.
Prakash J; de Borst MH; van Loenen-Weemaes AM; Lacombe M; Opdam F; van Goor H; Meijer DK; Moolenaar F; Poelstra K; Kok RJ
Pharm Res; 2008 Oct; 25(10):2427-39. PubMed ID: 18183478
[TBL] [Abstract][Full Text] [Related]
16. Heterozygous disruption of activin receptor-like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy.
Muñoz-Félix JM; López-Novoa JM; Martínez-Salgado C
Kidney Int; 2014 Feb; 85(2):319-32. PubMed ID: 23945497
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice.
Singh SP; Tao S; Fields TA; Webb S; Harris RC; Rao R
Dis Model Mech; 2015 Aug; 8(8):931-40. PubMed ID: 26092126
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction.
Baba I; Egi Y; Utsumi H; Kakimoto T; Suzuki K
Mol Med Rep; 2015 Dec; 12(6):8010-20. PubMed ID: 26498136
[TBL] [Abstract][Full Text] [Related]
19. Curcumin ameliorates renal fibrosis by inhibiting local fibroblast proliferation and extracellular matrix deposition.
Zhou X; Zhang J; Xu C; Wang W
J Pharmacol Sci; 2014; 126(4):344-50. PubMed ID: 25452269
[TBL] [Abstract][Full Text] [Related]
20. pNaKtide ameliorates renal interstitial fibrosis through inhibition of sodium-potassium adenosine triphosphatase-mediated signaling pathways in unilateral ureteral obstruction mice.
Cheng X; Song Y; Wang Y
Nephrol Dial Transplant; 2019 Feb; 34(2):242-252. PubMed ID: 29788096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]